Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

Miguel Angel Villalona-Calero; John Paul Diaz; Zuanel Diaz; Wenrui Duan; Eric Douglas Schroeder; Santiago Aparo; Troy Antony Gatcliffe; Alfredo Pedro Alonso; Sebastian Cuitiva; Federico Albrecht; Siddhartha A. Venkatappa; Victor Guardiola; Michael B. Troner; Sara M. Garrido; Gail Walker; Muni Rubens; Fernando I. De Zarraga; Hao Vuong

doi:10.1200/jco.2019.37.15_suppl.2555

Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

Miguel Angel Villalona-Calero
, John Paul Diaz
, Zuanel Diaz
, Wenrui Duan
, Eric Douglas Schroeder
, Santiago Aparo
, Troy Antony Gatcliffe
, Alfredo Pedro Alonso
, Sebastian Cuitiva
, Federico Albrecht
, Siddhartha A. Venkatappa
, Victor Guardiola
, Michael B. Troner
, Sara M. Garrido
, Gail Walker
, Muni Rubens
, Fernando I. De Zarraga
, Hao Vuong

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	37
DOIs	https://doi.org/10.1200/jco.2019.37.15_suppl.2555
State	Published - May 20 2019

Disciplines

Oncology
Pathology
Medicine and Health Sciences

Access to Document

10.1200/jco.2019.37.15_suppl.2555License: Unspecified

Cite this

Villalona-Calero, M. A., Diaz, J. P., Diaz, Z., Duan, W., Schroeder, E. D., Aparo, S., Gatcliffe, T. A., Alonso, A. P., Cuitiva, S., Albrecht, F., Venkatappa, S. A., Guardiola, V., Troner, M. B., Garrido, S. M., Walker, G., Rubens, M., De Zarraga, F. I., & Vuong, H. (2019). Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM). Journal of Clinical Oncology, 37. https://doi.org/10.1200/jco.2019.37.15_suppl.2555

Villalona-Calero, MA, Diaz, JP , Diaz, Z, Duan, W, Schroeder, ED, Aparo, S, Gatcliffe, TA, Alonso, AP, Cuitiva, S, Albrecht, F , Venkatappa, SA, Guardiola, V, Troner, MB, Garrido, SM, Walker, G, Rubens, M, De Zarraga, FI & Vuong, H 2019, 'Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).', Journal of Clinical Oncology, vol. 37. https://doi.org/10.1200/jco.2019.37.15_suppl.2555

@article{905262cb6a614f1bb37a82e1e6fc0e31,

title = "Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).",

author = "Villalona-Calero, \{Miguel Angel\} and Diaz, \{John Paul\} and Zuanel Diaz and Wenrui Duan and Schroeder, \{Eric Douglas\} and Santiago Aparo and Gatcliffe, \{Troy Antony\} and Alonso, \{Alfredo Pedro\} and Sebastian Cuitiva and Federico Albrecht and Venkatappa, \{Siddhartha A.\} and Victor Guardiola and Troner, \{Michael B.\} and Garrido, \{Sara M.\} and Gail Walker and Muni Rubens and \{De Zarraga\}, \{Fernando I.\} and Hao Vuong",

year = "2019",

month = may,

day = "20",

doi = "10.1200/jco.2019.37.15\_suppl.2555",

language = "American English",

volume = "37",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

AU - Villalona-Calero, Miguel Angel

AU - Diaz, John Paul

AU - Diaz, Zuanel

AU - Duan, Wenrui

AU - Schroeder, Eric Douglas

AU - Aparo, Santiago

AU - Gatcliffe, Troy Antony

AU - Alonso, Alfredo Pedro

AU - Cuitiva, Sebastian

AU - Albrecht, Federico

AU - Venkatappa, Siddhartha A.

AU - Guardiola, Victor

AU - Troner, Michael B.

AU - Garrido, Sara M.

AU - Walker, Gail

AU - Rubens, Muni

AU - De Zarraga, Fernando I.

AU - Vuong, Hao

PY - 2019/5/20

Y1 - 2019/5/20

UR - https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.2555

U2 - 10.1200/jco.2019.37.15_suppl.2555

DO - 10.1200/jco.2019.37.15_suppl.2555

M3 - Article

VL - 37

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

Disciplines

Access to Document

Other files and links

Cite this